203522-12-7 Usage
General Description
1-N-Cbz-4-Methylpiperidine-4-carboxylic acid is a chemical compound that is commonly used in organic synthesis and pharmaceutical research. It is a derivative of piperidine and contains a carboxylic acid and a Cbz (benzyloxycarbonyl) protecting group. The Cbz group can be removed under mild conditions, making this compound useful as an intermediate in the synthesis of various pharmaceuticals and biologically active molecules. Its structure and functional groups make it a versatile building block for the synthesis of complex organic compounds. Additionally, it has potential applications in the development of new pharmaceuticals and medicinal chemistry research.
Check Digit Verification of cas no
The CAS Registry Mumber 203522-12-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,3,5,2 and 2 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 203522-12:
(8*2)+(7*0)+(6*3)+(5*5)+(4*2)+(3*2)+(2*1)+(1*2)=77
77 % 10 = 7
So 203522-12-7 is a valid CAS Registry Number.
InChI:InChI=1/C15H19NO4/c1-15(13(17)18)7-9-16(10-8-15)14(19)20-11-12-5-3-2-4-6-12/h2-6H,7-11H2,1H3,(H,17,18)
203522-12-7Relevant articles and documents
HETEROCYCLIC SPIRO-COMPOUNDS AS AM2 RECEPTOR INHIBITORS
-
Page/Page column 148; 167, (2020/06/05)
Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: wherein R1, R2, R4, R5, R6, R7, R8, R9, R10,Z, X1, X2, X3, L2, HET, n and q are as defined herein. The compounds are inhibitors of adrenomedullin receptor subtype 2 (AM2). Also disclosed are the compounds for use in the treatment of diseases modulated AM2, including proliferative diseases such as cancer; pharmaceutical compositions comprising the compounds; methods for preparing the compounds; and intermediates useful in the preparation of the compounds.
PYRIDINE DERIVATIVES AND USE THEREOF AS UROTENSIN II ANTAGONISTS
-
Page/Page column 46-47, (2008/06/13)
The invention relates to novel pyridine derivatives of formula 1 and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and their use as neurohormonal antagonists, especially as urotensin II inhibitors.
